Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aapro

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
Schweizerische Medizinische Wochenschrift|November 14, 1987
[Quantitative detection and elimination of neuroblastoma cells in vitro. Comparative study of the efficacy of an immunomagnetic method and lymphokine-activated killer cells]M Kästli, M Aapro, K Blaser, et al.
Schweizerische Medizinische Wochenschrift|October 26, 1985
[Intensive treatment and autologous bone marrow transplantation in cases of leukemias and lymphomas in relapse]B Chapuis, C Helg, P Maurice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2012
Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. ironM Aapro, A Österborg, P Gascón, et al.
Critical Reviews in Oncology/Hematology|January 22, 2005
Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factorsA Minisini, S Spazzapan, D Crivellari, et al.
Oncology|September 17, 2011
Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemiaT D Szucs, P R Blank, M Schwenkglenks, et al.
Experimental Hematology|February 1, 1987
Quantity and nature of residual bone marrow T cells after treatment of the marrow with Campath-1C Irlé, M Kaestli, M Aapro, et al.
British Journal of Cancer|March 8, 2012
Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancerM Aapro, W Jelkmann, S N Constantinescu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 10, 2016
MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline updateA Molassiotis, M Aapro, J Herrstedt, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overviewS B Kaye, M Piccart, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Chemotherapy in elderly patients with colorectal cancerC H Köhne, A Grothey, C Bokemeyer, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Schweizerische Medizinische Wochenschrift|November 14, 1987
[Quantitative detection and elimination of neuroblastoma cells in vitro. Comparative study of the efficacy of an immunomagnetic method and lymphokine-activated killer cells]M Kästli, M Aapro, K Blaser, et al.
Schweizerische Medizinische Wochenschrift|October 26, 1985
[Intensive treatment and autologous bone marrow transplantation in cases of leukemias and lymphomas in relapse]B Chapuis, C Helg, P Maurice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2012
Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. ironM Aapro, A Österborg, P Gascón, et al.
Critical Reviews in Oncology/Hematology|January 22, 2005
Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factorsA Minisini, S Spazzapan, D Crivellari, et al.
Oncology|September 17, 2011
Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemiaT D Szucs, P R Blank, M Schwenkglenks, et al.
Experimental Hematology|February 1, 1987
Quantity and nature of residual bone marrow T cells after treatment of the marrow with Campath-1C Irlé, M Kaestli, M Aapro, et al.
British Journal of Cancer|March 8, 2012
Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancerM Aapro, W Jelkmann, S N Constantinescu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 10, 2016
MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline updateA Molassiotis, M Aapro, J Herrstedt, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overviewS B Kaye, M Piccart, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Chemotherapy in elderly patients with colorectal cancerC H Köhne, A Grothey, C Bokemeyer, et al.
Pageof 14